Schedule 13D ownership disclosure

MIRAGEN THERAPEUTICS, INC.

Security class unavailable · CUSIP: 60463E202

Event date: 2021-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
19.9900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-21-001414
Form type
SC 13D
Filer
Fairmount Funds Management LLC
CIK
CIK 1802528
Filed
Jan 05, 2021
Reporting period
Dec 31, 2021
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub